Body Fluids and STIs: What Carries Risk Beyond Semen and Vaginal Fluid

Published: April 2025 | Last updated: May 2026

Most STI conversations focus on semen and vaginal fluid, and for good reason: those are the highest-volume sources of infectious organisms during sex. But blood, saliva, breast milk, rectal mucus, and a few other fluids can also carry infection in the right conditions. The risk varies sharply by fluid and by pathogen. A blood splash onto broken skin is a meaningful HIV exposure; sharing a coffee cup with someone who has a cold sore is a different risk profile from kissing them; sweat at the gym is essentially never a concern.

This explainer is published by stdrapidtestkits.com, an at-home rapid STI test retailer. Where a route maps to a test we sell, such as our at-home STI test kits, we point to it; where it does not, we say so plainly. The rest walks through which fluids carry STIs, what raises or lowers the risk, where skin-to-skin contact fits in even when no fluid is involved, and how to think about real-world exposures. Calibrated worry beats paranoia, and it lines up better with what the CDC, WHO, and NHS actually say.

Which body fluids actually carry STIs?

Not every body fluid is a meaningful transmission route. Sorting fluids into rough risk tiers is the fastest way to get past myth and into useful prevention.

High-risk fluids

The fluids that reliably transmit one or more STIs in the right conditions:

• Semen and pre-ejaculate. The classic vehicles for HIV, gonorrhea, chlamydia, syphilis, hepatitis B, and trichomoniasis. Pre-ejaculate is a smaller volume but is not sterile, so withdrawal does not eliminate transmission risk.
• Vaginal and cervical fluid. Carries the same set of pathogens as semen during reciprocal exposure, plus is a route for HPV and HSV during direct mucosal contact.
• Rectal fluid and rectal mucus. Less a stand-alone vehicle and more a high-risk site. The rectal lining is a single-cell-layer columnar epithelium (compared with the multi-layered squamous epithelium of the vagina), it sits over a dense population of HIV-target immune cells, and it tears readily during anal intercourse. That anatomy is part of why receptive anal sex without a condom is the highest per-act sexual HIV exposure per CDC HIV transmission guidance.
• Blood. The most concentrated source of bloodborne viruses. Even tiny amounts on broken skin, mucous membranes, or shared sharp instruments can transmit HIV, hepatitis B, and hepatitis C.
• Breast milk. Documented transmission route for HIV and cytomegalovirus (CMV). HTLV-1, a less commonly discussed retrovirus, also spreads this way and is the primary route by which children acquire HTLV-1 in endemic regions.

Lower-risk fluids (with conditions)

These fluids can transmit specific infections but are not blanket high-risk:

• Saliva. Carries HSV-1, hepatitis B in some scenarios, CMV, and Epstein-Barr virus. HIV is present at very low levels in saliva and salivary enzymes inactivate the virus, which is why deep kissing is not considered a meaningful HIV route in CDC guidance unless visible blood is involved.
• Urine. Generally low-risk on its own. Chlamydia and gonorrhea organisms shed into urine from urethral infection, which is why urine-based lab testing exists in clinics, but urine itself is not a typical transmission medium in everyday contact.

Negligible-risk fluids

The fluids the public worries about most are usually the ones that matter least:

• Sweat. No documented STI transmission through intact sweat. Gym equipment, locker rooms, and shared seating are not realistic exposure routes.
• Tears. Trace viral particles have been detected in tears for some viruses (HIV at extremely low concentrations, Zika in case reports, CMV in some samples), but transmission via tears is not a documented STI route.
• Nasal secretions. Carry respiratory viruses, not STIs.

Knowing which tier a fluid sits in lets you scale your response to the actual risk, instead of treating every body-fluid contact as a crisis. The way CDC STI fact sheets and the World Health Organization's STI fact sheet describe transmission lines up with the tiers above.

How the fluids map to common STIs

The tiers above translate into a simple cross-reference. Read each row as a fluid and each column as a pathogen: 'High' means a well-documented route, 'Possible' means it happens only under specific conditions, and 'Not the typical route' means transmission by that fluid is not how the infection usually spreads.

Blood: why even tiny exposures matter

Of every body fluid, blood is the most efficient at transmitting infection. Bloodborne viruses circulate at high concentrations, so a small volume of blood can carry a relatively large infectious dose. The three pathogens most relevant here are HIV, hepatitis B, and hepatitis C.

Hepatitis B is unusually durable

Hepatitis B survives outside the body far longer than people expect. Per CDC hepatitis B clinical-overview guidance, the virus is infectious for at least 7 days on surfaces. That changes the math for shared razors, toothbrushes contaminated with bleeding gums, unsterilized tattoo or piercing equipment, and shared injection equipment. Vaccination is the most effective defense; the hepatitis B vaccine is now part of routine childhood immunization in most countries.

HIV transmission via blood

HIV is fragile outside the body and dies within minutes of drying on most surfaces. The risk scenarios that matter are fresh blood-to-blood or blood-to-mucous-membrane contact: shared injection-drug needles, occupational needlestick injuries in healthcare, and unprotected sexual contact when a partner is bleeding (menstrual blood, an open sore). Per CDC HIV information, casual contact, hugging, and sharing dishes are not transmission routes.

Hepatitis C: mostly bloodborne

Hepatitis C transmits almost exclusively through blood-to-blood contact in modern settings. Per the CDC hepatitis C fact sheet, injection-drug use is the most commonly reported risk factor, linked to about 43% of 2023 U.S. cases that had risk information. Sexual transmission of HCV is uncommon but documented, particularly among men who have sex with men who also have HIV. Shared injection equipment and unsafe medical or tattooing practices remain the dominant risk worldwide.

Other bloodborne viruses worth naming

HTLV-1 and HTLV-2 (human T-lymphotropic viruses) transmit through blood, breast milk, and sexual contact. They are less common in most regions than the trio above, but they belong on the bloodborne map. Syphilis can also pass through transfusion or shared injection equipment in theory, though screened blood supplies and the bacterium's sensitivity to drying make this rare.

Real scenarios where blood exposure happens

• Sharing razors or toothbrushes with someone who has bleeding gums or shaving nicks. Uncommon, but technically possible for hepatitis B and C.
• Unregulated tattoo, piercing, or needling work. Reused or improperly sterilized equipment is a documented hepatitis B and C transmission route.
• Healthcare and caregiving exposures. Needlesticks, mucosal splashes, and contact with open wounds. Personal protective equipment exists for a reason.
• Sex during menstruation or with an active genital sore without barriers. Adds blood to an already-existing fluid exchange.

Saliva and oral contact: sorting fact from fear

Saliva is the body fluid most people overestimate the danger of for HIV and underestimate the danger of for herpes. Both directions of confusion are worth correcting.

Why saliva is not a meaningful HIV route

HIV is present in saliva at very low concentrations, and salivary proteins (mucins, secretory leukocyte protease inhibitor) interfere with the virus. The CDC has stated for decades that kissing, sharing eating utensils, and other saliva contact are not HIV transmission routes in the absence of visible blood. The narrow exception involves deep kissing when both partners have active mouth bleeding, an unusual combination.

Why saliva is a meaningful herpes route

HSV-1, the virus most commonly responsible for cold sores, transmits readily through oral contact, and asymptomatic shedding is the rule rather than the exception. Per CDC genital herpes guidance, most people with herpes have no or very mild symptoms and do not know they are infected, and transmission often happens when the carrier has no visible sore. In practice:

• Kissing during an active outbreak is the highest-risk moment, but transmission is possible between outbreaks.
• Oral-to-genital contact can transmit HSV-1 to the genitals, where it presents as genital herpes. A meaningful share of new genital herpes diagnoses are HSV-1 acquired through oral sex (we cover this in more depth in our guide to the real risks of oral sex).
• Shared lip balm, drinks, or utensils carry a small but real transmission risk during the window when the virus is shedding.

Other infections that travel via saliva or oral contact

Hepatitis B can be present in saliva and transmission has been documented in close-contact household settings, particularly between partners or caregivers. A syphilis chancre on the lip or inside the mouth can transmit the bacterium through kissing or oral contact, though this is uncommon. Pharyngeal gonorrhea is established when a partner's oral mucosa contacts infected genital secretions during oral sex (saliva itself is not the vehicle; oral exposure to genital fluid is). CMV and Epstein-Barr virus pass routinely via saliva, which is why EBV picked up the nickname 'the kissing disease.' These are not strictly STIs but they are common, and they share saliva as a route.

Oral Herpes (HSV-1) At-Home Antibody Test

Oral Herpes-1 At-Home Rapid Self-Test Kit

$59.00

Fingerstick blood antibody test for HSV-1, the virus behind most cold sores and a meaningful share of new genital herpes cases via oral sex. Useful 12 or more weeks after a suspected exposure, once antibody levels have had time to develop. This is a blood antibody test, not a swab of an active sore; for a current outbreak, see a clinician for swab-based testing of the lesion.

See the HSV-1 antibody test

Skin-to-skin contact: the route that isn't a fluid at all

A fluid-only mental model leaves three meaningful STIs out. The following pathogens transmit primarily by direct skin-to-skin or mucosa-to-mucosa contact:

• Human papillomavirus (HPV). More than 200 known strains, around 14 of which are linked to cancer risk, plus several that cause genital warts. HPV transmits through genital skin contact during vaginal, anal, or oral sex. Condoms reduce risk substantially but do not cover every site of potential contact, so vaccination is the durable defense.
• Herpes simplex virus (HSV-1 and HSV-2). Sheds from skin and mucosa in the area of past outbreaks, often when no lesion is visible. Most HSV-2 transmission events come from partners who do not know they carry the virus.
• Syphilis (primary stage). Direct contact with the chancre, the painless sore that appears at the site of inoculation, transmits the infection. The chancre can sit on genitals, anus, lips, or inside the mouth.

Pubic lice and scabies sit in a related category: parasites that transfer through close body contact rather than through any fluid. They are parasitic rather than viral or bacterial, and they appear in the same sexual-health conversations because their exposure routes overlap with those of STIs.

The practical implication: HPV, genital herpes, and primary syphilis can pass between partners who used condoms correctly and avoided fluid exchange. Routine HPV vaccination, type-specific HSV antibody testing for partners considering condomless sex, and prompt evaluation of any new genital sore close most of the remaining preventable risk.

Breast milk, pregnancy, and vertical transmission

Vertical transmission (from a pregnant or breastfeeding parent to an infant) is its own category of risk and is one of the public-health success stories of the last three decades.

HIV and breastfeeding

Without intervention, an HIV-positive parent can transmit the virus to their infant during pregnancy, delivery, or breastfeeding. Combined antiretroviral therapy taken consistently changes that picture dramatically. Per CDC infant-feeding guidance, for a mother on antiretroviral therapy with a sustained undetectable viral load the risk of transmission through breastfeeding is less than 1%, though not zero, and current guidance supports shared, patient-centered decision-making about feeding options.

HTLV-1 and breastfeeding

HTLV-1 is the less famous member of this story. Prolonged breastfeeding is the dominant route by which children acquire HTLV-1 in endemic regions, and WHO plus several national guidelines recommend formula feeding for HTLV-1-positive parents where safe alternatives exist. Routine prenatal HTLV-1 screening is done in some countries (notably Japan) but not universally.

Hepatitis B and pregnancy

Hepatitis B can be passed at birth. Routine hepatitis B vaccination of newborns within 24 hours, combined with hepatitis B immune globulin when the parent is positive, prevents the vast majority of infant infections.

Syphilis and congenital infection

Untreated syphilis during pregnancy can cause miscarriage, stillbirth, or congenital syphilis with serious infant complications. Routine prenatal syphilis screening and timely penicillin treatment are highly effective at preventing congenital cases. Rising adult syphilis rates have driven a corresponding rise in congenital cases in several countries, which is why universal prenatal screening is the standard of care.

Sweat, tears, urine, and everyday surfaces

The body fluids people most often worry about turn out to be safer than expected. None of sweat, tears, or urine are documented routes of meaningful STI transmission in everyday, intact-skin contact.

Sweat does not carry HIV, hepatitis B, hepatitis C, herpes, syphilis, gonorrhea, or chlamydia in any clinically meaningful way. Gym equipment, sauna benches, and shared yoga mats are not STI risks. They are still worth wiping down for general hygiene, but the concern there is bacterial skin infection, not STIs.

Tears have shown trace viral particles in laboratory studies for some viruses, but no STI is established as transmissible by tear contact, even directly onto a mucous membrane.

Urine is more nuanced. People confuse urine being a diagnostic sample for chlamydia and gonorrhea (organisms shed into first-catch urine and can be detected in the lab) with urine being a transmission route. It is the first, not the second. You do not catch chlamydia or gonorrhea from urine on a toilet seat, in a swimming pool, or through any environmental urine exposure.

Casual contact like shaking hands, hugging, sharing toilets, sharing dishes, or closed-mouth or 'social' kissing with a person with HIV does not result in HIV transmission.

Shared items that genuinely deserve caution

A useful worry list is short and specific. These are the everyday items where transmission is biologically plausible, and where simple habits close the gap. The UK's NHS STI guidance reaches the same practical conclusions.

• Razors and toothbrushes used by someone with bleeding gums or shaving nicks. Hepatitis B is the main concern because it survives in dried blood. Keep them personal.
• Unsterilized tattoo, piercing, or acupuncture equipment. Reused needles transmit hepatitis B and C and, rarely, HIV. Use licensed studios with single-use needles.
• Sex toys shared without a barrier or cleaning between partners. They carry the same fluid-exchange risk as direct contact for HIV, herpes, HPV, hepatitis B, and bacterial STIs.
• Manicure and pedicure tools that have not been autoclaved. A documented, if uncommon, hepatitis route.

If you provide care for someone with a wound, basic precautions cover the realistic exposures: disposable gloves for blood cleanup, hand-washing around mucous membranes or open wounds, and prompt cleaning of blood spills. Vaccinated caregivers (the hepatitis B vaccine is routine) carry far lower risk than people assume.

When to test after a worrying exposure

If an exposure has you concerned, the most useful question is: what window period does the test cover, and what should I do in the meantime? Per CDC HIV testing guidance and FDA assay-label statements, conservative ranges look like this:

• HIV (fourth-generation antigen-antibody lab test): reliable detection roughly 18 to 45 days post-exposure. Rapid antibody tests, including most at-home kits, typically detect infection between 23 and 90 days. The conservative answer for ruling out infection with a home antibody test is 90 days.
• Hepatitis B surface antigen: generally detectable within 30 to 60 days post-exposure; most infections are detectable by week 8 to 12.
• Hepatitis C antibodies: typically detectable 8 to 12 weeks post-exposure; conservative ruling-out window is 12 weeks.
• Syphilis (treponemal antibody test, the standard blood screen): usually reactive 3 to 6 weeks post-exposure; CDC and most clinical guidance recommend re-testing at 12 weeks after a known exposure.
• Chlamydia and gonorrhea: reliable from roughly 1 to 2 weeks post-exposure on the appropriate sample site.
• Herpes (HSV antibody tests): roughly 6 to 12 weeks for confident seroconversion; some FDA-cleared assays note outliers up to 16 weeks.

For high-risk HIV exposures (needlestick, sexual assault, condom failure with a known-positive partner), HIV post-exposure prophylaxis (PEP) is a 28-day antiretroviral course that reduces infection risk substantially. PEP must start within 72 hours of exposure, and earlier is significantly better, so contact a clinic or emergency department promptly rather than waiting to test. Hepatitis B has its own post-exposure prophylaxis (vaccine plus immune globulin) that works well within 24 hours of a known exposure to a positive source. Once the right window has passed, an at-home HIV test or a broader panel can screen the blood-borne concerns from the exposure.

Where at-home testing fits

We recommend tests based on the route you are worried about rather than on selling the widest panel. Once the right window has passed, a home test is a private, fast way to screen the most common blood-borne concerns after an exposure event.

Be precise about the technology. Our kits are lateral-flow immunoassays, the same general chemistry used in COVID-19 and pregnancy rapid tests, run on a fingerstick blood drop or a self-collected genital swab. Laboratories use NAAT or quantitative serology, which have higher analytical sensitivity. The two are complementary, not interchangeable: a home test is a strong screening layer with high negative predictive value once the window has passed, and any reactive (positive) result should be confirmed by a lab. A home test fits well when you want to rule out infection after the window. See a clinic instead when you need to confirm a positive, when you are testing too soon for antibodies to show, or when the exposure involved a site our kits do not cover (pharyngeal, rectal, or intrauterine), since we do not sell throat or rectal swabs. For someone whose exposure spanned several routes, one broad panel is usually more practical than a stack of single-infection kits.

7-in-1 At-Home STI Test Kit

Complete STD At-Home Rapid Self-Test Kit

$413.00

Rapid lateral-flow panel covering HIV, syphilis, hepatitis B, hepatitis C, chlamydia, gonorrhea, and herpes. Useful when an exposure event has you wanting a broad screen across blood-borne and genital routes rather than a single-pathogen test. Mixed sample types (fingerstick blood plus self-collected genital swab) following the kit instructions. Results at home in about 15 minutes. Confirm any reactive result with a laboratory test.

See the 7-in-1 panel

Stigma, honesty, and the cost of bad information

Most people with an STI didn't get it through anything reckless. Asymptomatic carriers exist for almost every STI worth tracking. HSV-1 prevalence is roughly 64% of adults under 50 per the WHO herpes simplex virus fact sheet; HPV prevalence is similarly high among sexually active adults; many chlamydia and gonorrhea infections cause no symptoms in the early weeks. Because infection often shows no signs (NIH MedlinePlus makes the same point), routine screening rather than waiting for symptoms is the standard recommendation from CDC and WHO.

Outdated sex education has made this worse. Most school programs focus narrowly on pregnancy prevention and HIV avoidance and skip the practical biology of saliva, breast milk, dried blood on shared items, skin-to-skin viral transmission, and asymptomatic shedding. The result is a generation of adults who panic about toilet seats and shrug off cold sores, which is roughly the opposite of what the actual risk profile would suggest.

Honest conversations with partners, clinicians, and, when relevant, household members are the strongest single prevention tool. 'I've had cold sores in the past' or 'I'd like both of us to test before we stop using condoms' is uncomfortable for thirty seconds and clarifying for the rest of the relationship. The same logic applies when you are the one with a recent exposure: state it early, test when the window allows, and confirm any positive home result at a lab so the answer is reliable.

Your next step, in order

If a specific exposure is on your mind, work through the questions below in order. They map the exposure to a concrete action: urgent care first when timing matters, then testing once the window allows, then confirmation of any reactive result.

1. U.S. Centers for Disease Control and Prevention. How HIV is transmitted: the fluids that transmit HIV, the highest per-act risk routes, and the saliva/sweat/tears non-routes.
2. U.S. Centers for Disease Control and Prevention. HIV testing types and window periods, including antigen/antibody (18 to 45 days) and antibody/rapid (23 to 90 days) assays.
3. U.S. Centers for Disease Control and Prevention. Hepatitis B clinical overview: transmission and surface survival of at least 7 days in dried blood, plus vaccination guidance.
4. U.S. Centers for Disease Control and Prevention. Hepatitis C: bloodborne transmission and current U.S. exposure patterns (injection-drug use the most commonly reported risk factor).
5. U.S. Centers for Disease Control and Prevention. About genital herpes: HSV-1 and HSV-2 transmission, asymptomatic infection, and shedding.
6. World Health Organization. Herpes simplex virus fact sheet: global HSV-1 prevalence (about 3.8 billion people under 50, roughly 64%), transmission, and symptoms.
7. U.K. National Health Service. Sexually transmitted infections: transmission, symptoms, and testing pathways.
8. U.S. National Institutes of Health, MedlinePlus. Sexually transmitted infections: how they spread and why many cause no symptoms.

Maya Chen

Maya writes plain-English explainers on STI screening, prevention, and at-home testing. Background in epidemiology research at a state public-health department; articles synthesize CDC and peer-reviewed guidance, not personal clinical advice.